Altimmune commences enrollment in phase 1 clinical trial of adcovid™ -- a needle-free, single-dose intranasal covid-19 vaccine candidate

Nasal spray may offer room temperature distribution that could reduce logistical challenges for healthcare systems and providers

ALT Ratings Summary

ALT Quant Ranking